Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 146 entries
View as:

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)

Phase: N/A Priority: Normal
NCT ID: NCT02338570 Org: User:
Start: 07/31/15 End: 02/28/18 Due: 02/28/19

Telmisartan Versus Losartan in Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01224860 Org: User:
Start: 01/31/09 End: 01/31/14 Due: 01/31/15

MOR202 for Refractory MN

Phase: N/A Priority: Normal
NCT ID: NCT04893096 Org: User:
Start: 10/22/21 End: 02/21/25 Due: 02/21/26

Acetylcarnitine and Insulin Sensitivity

Phase: N/A Priority: Normal
NCT ID: NCT00393770 Org: User:
Start: 02/29/04 End: 09/30/07 Due: 09/30/08

MuLtidimensional School-based and Family interVentions to Promote hEalthy and Sustainable LifestYle for the Childhood

Phase: N/A Priority: Normal
NCT ID: NCT05966051 Org: User:
Start: 10/18/23 End: 06/01/25 Due: 06/01/26

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT06121401 Org: User:
Start: 09/15/23 End: 09/15/27 Due: 09/15/28

Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino)

Phase: N/A Priority: Normal
NCT ID: NCT04361916 Org: User:
Start: 04/21/20 End: 06/30/20 Due: 06/30/21

Phase II Study of Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen (AUSTRAL)

Phase: N/A Priority: Normal
NCT ID: NCT06680050 Org: User:
Start: 01/31/25 End: 01/31/28 Due: 01/31/29

Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach

Phase: N/A Priority: Normal
NCT ID: NCT01640782 Org: User:
Start: 02/28/05 End: 01/31/13 Due: 01/31/14

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00494715 Org: User:
Start: 05/31/07 End: 04/30/16 Due: 04/30/17

ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)

Phase: N/A Priority: Normal
NCT ID: NCT01989858 Org: User:
Start: 11/30/10 End: 12/31/13 Due: 12/31/14

Statins in Proteinuric Nephropathies

Phase: N/A Priority: Normal
NCT ID: NCT00199927 Org: User:
Start: 03/31/03 End: 03/31/08 Due: 03/31/09

LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B)

Phase: N/A Priority: Normal
NCT ID: NCT05791929 Org: User:
Start: 04/13/23 End: 12/04/23 Due: 12/04/24

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT01377246 Org: User:
Start: 05/31/11 End: 10/18/17 Due: 10/18/18

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01735071 Org: User:
Start: 07/31/13 End: 03/18/18 Due: 03/18/19

1 Vs 7 RATG Infusions in Renal Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06374095 Org: User:
Start: 07/30/24 End: 09/30/25 Due: 09/30/26

Patiromer and Diet/hrQoL in Chronic Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT06858280 Org: User:
Start: 06/15/25 End: 02/28/26 Due: 02/28/27

Kidney Perfusion With or Without Absorption

Phase: N/A Priority: Normal
NCT ID: NCT06374121 Org: User:
Start: 10/22/24 End: 05/31/26 Due: 05/31/27

Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib

Phase: N/A Priority: Normal
NCT ID: NCT03314740 Org: User:
Start: 06/12/17 End: 04/01/21 Due: 04/01/22

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Phase: N/A Priority: Normal
NCT ID: NCT02194231 Org: User:
Start: 07/31/13 End: 12/12/19 Due: 12/12/20

Artificial Intelligence-based Techniques to Characterize KIdney Microstructure on Histological ImagEs

Phase: N/A Priority: Normal
NCT ID: NCT06690190 Org: User:
Start: 11/08/24 End: 11/30/34 Due: 11/30/35

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study

Phase: N/A Priority: Normal
NCT ID: NCT03917173 Org: User:
Start: 06/01/20 End: 06/01/25 Due: 06/01/26

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT01220050 Org: User:
Start: 09/30/09 End: 02/28/13 Due: 02/28/14

Simulated and Synthetic Health Data: Improving Clinical Research on Rare Diseases. A Real-World Data Simulation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trials. A Retrospective, Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT07016282 Org: User:
Start: 06/30/25 End: 06/30/27 Due: 06/30/28

Tolvaptan for In-hospital Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT01386372 Org: User:
Start: 06/30/11 End: 11/30/12 Due: 11/30/13